Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Building a robust 21st century chemical testing program at the U.S. Environmental Protection Agency: recommendations for strengthening scientific engagement.

McPartland J, Dantzker HC, Portier CJ.

Environ Health Perspect. 2015 Jan;123(1):1-5. doi: 10.1289/ehp.1408601. Epub 2014 Oct 24.

2.

Inconclusive findings: now you see them, now you don't!

Portier CJ, Goldman LR, Goldstein BD.

Environ Health Perspect. 2014 Feb;122(2):A36. doi: 10.1289/ehp.1408106. No abstract available.

3.

Blood lead level association with lower body weight in NHANES 1999-2006.

Scinicariello F, Buser MC, Mevissen M, Portier CJ.

Toxicol Appl Pharmacol. 2013 Dec 15;273(3):516-23. doi: 10.1016/j.taap.2013.09.022. Epub 2013 Oct 4.

PMID:
24099784
4.

Biological networks for predicting chemical hepatocarcinogenicity using gene expression data from treated mice and relevance across human and rat species.

Thomas R, Thomas RS, Auerbach SS, Portier CJ.

PLoS One. 2013 May 30;8(5):e63308. doi: 10.1371/journal.pone.0063308. Print 2013.

5.

Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: perspectives across chemicals.

Aylward LL, Kirman CR, Schoeny R, Portier CJ, Hays SM.

Environ Health Perspect. 2013 Mar;121(3):287-94. doi: 10.1289/ehp.1205740. Epub 2012 Dec 11.

6.

Gene expression networks.

Thomas R, Portier CJ.

Methods Mol Biol. 2013;930:165-78. doi: 10.1007/978-1-62703-059-5_7.

PMID:
23086841
7.

ATSDR in the 21st century.

Portier CJ.

J Environ Health. 2012 Mar;74(7):30-1. No abstract available.

PMID:
22428320
8.

A signal-to-noise crossover dose as the point of departure for health risk assessment.

Sand S, Portier CJ, Krewski D.

Environ Health Perspect. 2011 Dec;119(12):1766-74. doi: 10.1289/ehp.1003327. Epub 2011 Aug 3.

9.

Comprehensive environmental public health.

Portier CJ.

Public Health Rep. 2011 May-Jun;126 Suppl 1:3-6. No abstract available.

10.

Estimating the global public health implications of electricity and coal consumption.

Gohlke JM, Thomas R, Woodward A, Campbell-Lendrum D, Prüss-Üstün A, Hales S, Portier CJ.

Environ Health Perspect. 2011 Jun;119(6):821-6. doi: 10.1289/ehp.1002241. Epub 2011 Feb 21. Erratum in: Environ Health Perspect. 2014 Nov;122(11):A295.

11.

Global gene expression profiling of a population exposed to a range of benzene levels.

McHale CM, Zhang L, Lan Q, Vermeulen R, Li G, Hubbard AE, Porter KE, Thomas R, Portier CJ, Shen M, Rappaport SM, Yin S, Smith MT, Rothman N.

Environ Health Perspect. 2011 May;119(5):628-34. doi: 10.1289/ehp.1002546. Epub 2010 Dec 13.

12.

Expression and function of 5-hydroxytryptamine 4 receptors in smooth muscle preparations from the duodenum, ileum, and pelvic flexure of horses without gastrointestinal tract disease.

Prause AS, Guionaud CT, Stoffel MH, Portier CJ, Mevissen M.

Am J Vet Res. 2010 Dec;71(12):1432-42. doi: 10.2460/ajvr.71.12.1432.

PMID:
21117994
13.

Employing a Mechanistic Model for the MAPK Pathway to Examine the Impact of Cellular all or None Behavior on Overall Tissue Response.

Luke NS, Devito MJ, Portier CJ, El-Masri HA.

Dose Response. 2010 Jan 29;8(3):347-67. doi: 10.2203/dose-response.09-017.Luke.

14.

What role for biologically based dose-response models in estimating low-dose risk?

Crump KS, Chen C, Chiu WA, Louis TA, Portier CJ, Subramaniam RP, White PD.

Environ Health Perspect. 2010 May;118(5):585-8. doi: 10.1289/ehp.0901249. Epub 2010 Jan 4. Review.

15.

Approaches for assessing risks to sensitive populations: lessons learned from evaluating risks in the pediatric population.

Hines RN, Sargent D, Autrup H, Birnbaum LS, Brent RL, Doerrer NG, Cohen Hubal EA, Juberg DR, Laurent C, Luebke R, Olejniczak K, Portier CJ, Slikker W.

Toxicol Sci. 2010 Jan;113(1):4-26. doi: 10.1093/toxsci/kfp217. Epub 2009 Sep 21. Review.

16.

A discrete time model for the analysis of medium-throughput C. elegans growth data.

Smith MV, Boyd WA, Kissling GE, Rice JR, Snyder DW, Portier CJ, Freedman JH.

PLoS One. 2009 Sep 15;4(9):e7018. doi: 10.1371/journal.pone.0007018.

17.

Application of a mathematical model to describe the effects of chlorpyrifos on Caenorhabditis elegans development.

Boyd WA, Smith MV, Kissling GE, Rice JR, Snyder DW, Portier CJ, Freedman JH.

PLoS One. 2009 Sep 15;4(9):e7024. doi: 10.1371/journal.pone.0007024.

18.

AhR-mediated gene expression in the developing mouse telencephalon.

Gohlke JM, Stockton PS, Sieber S, Foley J, Portier CJ.

Reprod Toxicol. 2009 Nov;28(3):321-8. doi: 10.1016/j.reprotox.2009.05.067. Epub 2009 May 22.

19.

Genetic and environmental pathways to complex diseases.

Gohlke JM, Thomas R, Zhang Y, Rosenstein MC, Davis AP, Murphy C, Becker KG, Mattingly CJ, Portier CJ.

BMC Syst Biol. 2009 May 5;3:46. doi: 10.1186/1752-0509-3-46.

20.

Choosing the right path: enhancement of biologically relevant sets of genes or proteins using pathway structure.

Thomas R, Gohlke JM, Stopper GF, Parham FM, Portier CJ.

Genome Biol. 2009;10(4):R44. doi: 10.1186/gb-2009-10-4-r44. Epub 2009 Apr 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk